Abstract 1738P
Background
Tobacco remains the leading preventable risk factor for cancer in the world. Although the prevalence of tobacco use has a decreasing trend in most European countries, the availability of new smoking devices is causing an increase in smokers, especially among the younger population. Several studies have confirmed the relationship between this increase and indirect or covert advertising, carried out on social media and VOD platforms, through product placement, etc. This study aims to measure the impact of tobacco and new smoking devices in these digital spaces on the young Spanish population; and how this impact is related to increased consumption.
Methods
A survey has been conducted on the young Spanish population (aged between 16 to 21 years old) using a representative online panel of this population. The final sample obtained was 1730 interviews, and the data collection was conducted in December 2022. A questionnaire with an average duration of 10 minutes was administered, in which questions related to tobacco and new smoking devices use, and the recall of having seen content related to traditional tobacco and new smoking devices were collected. Descriptive and logistic regression analyses have been performed, taking the habitual consumption (last month) of tobacco and new smoking device as dependent variables.
Results
82.5% of young people remember having had some impact related to traditional tobacco, and 83% with new smoking forms. Among young people who have had this impact, there are twice as many smokers (53.1%) as among those who have not (24.5%). Having seen someone smoking cigarettes on these platforms (AOR 1.56), cigarette product placement (AOR 1.71), or recalling e-cigarette brands (AOR 1.58) are the variables that most increase the risk of regularly consuming traditional cigarettes. The same happens in the risk of habitual consumption of new devices, with the recall of having seen specific brands or logos taking special relevance (AOR 2.47).
Conclusions
There is a correlation between the recall of these types of consumption and the regular consumption of tobacco or new forms of smoking. It is necessary to continue researching this avenue of normalization of consumption and to ensure the protection of young people from the promotion of new devices.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Asociación Española Contra el Cáncer.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1716P - Addressing clinical trial disparities in Spain: A digital solution
Presenter: Max Hardy-Werbin
Session: Poster session 23
1717P - Management of patients during a digital healthcare record system transition: A phase I unit experience
Presenter: Lyra Del Rosario
Session: Poster session 23
1718P - Impact of the economic status of the patient's country of residence on the outcome of oncology clinical trials
Presenter: Saki Nishiyama
Session: Poster session 23
1719P - Decentralized clinical trials: Is there a space in Italy?
Presenter: Celeste Cagnazzo
Session: Poster session 23
1720P - Experience in the provision of oncology services immediately after a major disaster
Presenter: Burak Aktas
Session: Poster session 23
1721P - Self-assessment tool and best-practice sharing to support hospitals in improving the quality of multi-disciplinary teams in lung cancer care
Presenter: Ernest Nadal
Session: Poster session 23
1722P - Factors contributing to differences in evidence compliance rate in cancer treatment among second opinion cases
Presenter: Tomomi Sanomachi
Session: Poster session 23
1723P - Improving access to molecular tumour boards for complex genomic profiles: A healthcare policy from the Netherlands
Presenter: Sahar van Waalwijk van Doorn-Khosrovani
Session: Poster session 23
1724P - Improving access to breast cancer diagnosis and treatment through navigation: Evaluation of a one-year pilot project in Botswana
Presenter: Ariane Migeotte
Session: Poster session 23
1725P - Genetic counselling for cancer in EU member states: Review and foundation for consensus recommendations
Presenter: J. Matt McCrary
Session: Poster session 23